Kolexia
Willaume Alexandre
Hématologie
Hôpital Saint Vincent de Paul Lille
Lille, France
42 Activités
22 Followers

Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Lymphomes Lymphome B Lymphome B diffus à grandes cellules Amyloïdose Myélome multiple Lymphopénie Aberrations des chromosomes Diarrhée Hypoxie

Industries

Janssen
4 collaboration(s)
Dernière en 2023
Amgen
2 collaboration(s)
Dernière en 2021
Abbvie
1 collaboration(s)
Dernière en 2022
Sandoz
1 collaboration(s)
Dernière en 2020

Dernières activités

High PDL1/PDL2 gene expression correlates with worse outcome in primary mediastinal large B-cell lymphoma.
Blood advances   20 octobre 2023
MOLECULAR CHARACTERIZATION CONTRIBUTES TO DIAGNOSIS AND PREDICTS OUTCOME IN PRIMARY MEDIASTINAL LARGE B-CELL LYMPHOMAS: A LYSA STUDY
17th International Conference on Malignant Lymphoma, Palazzo dei Congressi, Lugano, Switzerland, 13 ‐ 17 June, 2023   09 juin 2023
Prognostic Value of Lymphopenia and Total Metabolic Tumor Volume in Diffuse Large Cell Lymphoma of B Phenotype in the RT3 and REMARC trials—A LYSA retrospective analysis
17th International Conference on Malignant Lymphoma, Palazzo dei Congressi, Lugano, Switzerland, 13 ‐ 17 June, 2023   09 juin 2023
Topic: AS01-Diagnosis/AS01c-Molecular aberrations (cytogenetic, genetic, gene expression): PRATICAL USE OF MONOCYTE SUBSET BY FLOW CYTOMETRY AND SEQUENCING IN DIAGNOSIS AND PROGNOSIS OF CLINICAL RELEVANT MONOCYTOSIS
The 17th International Congress on Myelodysplastic Syndromes   01 mai 2023
Evaluation of a convolution neural network for baseline total tumor metabolic volume on FFDG PET in diffuse large B cell lymphoma.
European radiology   04 janvier 2023
Prognostic Value of Lymphopenia and Total Metabolic Tumor Volume in Diffuse Large Cell Lymphoma of B Phenotype
Annual Meeting Abstracts 2022   15 novembre 2022
Outcomes after first-line immunochemotherapy for primary mediastinal B-cell lymphoma: a LYSA study.
Blood advances   01 novembre 2021
OUTCOMES AFTER FIRST-LINE IMMUNOCHEMOTHERAPY FOR PRIMARY MEDIASTINAL B CELL LYMPHOMA PATIENTS: A LYSA STUDY
16th International Conference on Malignant Lymphoma, Virtual Edition, 18–22 June, 2021   17 juin 2021
050 | OUTCOMES AFTER FIRST-LINE IMMUNOCHEMOTHERAPY FOR PRIMARY MEDIASTINAL B CELL LYMPHOMA PATIENTS: A LYSA STUDY
16th International Conference on Malignant Lymphoma, Virtual Edition, 18–22 June, 2021   09 juin 2021
A new role of glutathione peroxidase 4 during human erythroblast enucleation.
Blood advances   14 mai 2021